Status:
RECRUITING
The Hong Kong Diabetes Biobank
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Diabetes Mellitus
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
Asia is in the midst of an epidemic of diabetes. Epidemiological figures suggest that there are more than 110 million people affected by diabetes in China, with a significant proportion of young adult...
Detailed Description
The Hong Kong Diabetes Biobank leverages on the existing infrastructure of clinical assessment for people with diabetes. Subjects undergoing routine diabetes complications screen at different diabete...
Eligibility Criteria
Inclusion
- subjects with known diabetes
Exclusion
- subjects not capable of giving written informed consent
Key Trial Info
Start Date :
February 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2063
Estimated Enrollment :
48000 Patients enrolled
Trial Details
Trial ID
NCT05282680
Start Date
February 1 2014
End Date
December 31 2063
Last Update
March 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Shatin, Hong Kong